Experts help bring first-of-its-kind drug for metabolic liver disease to the clinic
Liver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known ...
Mar 15, 2024
0
2